{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T12:40:02Z","timestamp":1788871202346,"version":"build-2803163510"},"reference-count":56,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2010,7,1]],"date-time":"2010-07-01T00:00:00Z","timestamp":1277942400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2010,7,1]],"date-time":"2010-07-01T00:00:00Z","timestamp":1277942400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001412","name":"Council of Scientific and Industrial Research, India","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001412","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Brain Research"],"published-print":{"date-parts":[[2010,7]]},"DOI":"10.1016\/j.brainres.2010.05.010","type":"journal-article","created":{"date-parts":[[2010,5,14]],"date-time":"2010-05-14T04:29:46Z","timestamp":1273811386000},"page":"192-199","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":22,"special_numbering":"C","title":["Salicylic acid protects against chronic l-DOPA-induced 6-OHDA generation in experimental model of parkinsonism"],"prefix":"10.1016","volume":"1344","author":[{"given":"Anupom","family":"Borah","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kochupurackal P.","family":"Mohanakumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.brainres.2010.05.010_bib1","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1007\/BF00978370","article-title":"The determination of hydroxydopamines and other trace amines in the urine of parkinsonian patients and normal controls","volume":"18","author":"Andrew","year":"1993","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.brainres.2010.05.010_bib2","doi-asserted-by":"crossref","first-page":"1635","DOI":"10.1046\/j.1471-4159.1998.71041635.x","article-title":"Aspirin and salicylate protect against MPTP-induced dopamine depletion in mice","volume":"71","author":"Aubin","year":"1998","journal-title":"J. Neurochem."},{"key":"10.1016\/j.brainres.2010.05.010_bib3","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1007\/s10571-007-9213-6","article-title":"Long-term l-DOPA treatment causes indiscriminate increase in dopamine levels at the cost of serotonin synthesis in discrete brain regions of rats","volume":"27","author":"Borah","year":"2007","journal-title":"Cell. Mol. Neurobiol."},{"key":"10.1016\/j.brainres.2010.05.010_bib4","doi-asserted-by":"crossref","first-page":"160","DOI":"10.5214\/ans.0972.7531.2009.160406","article-title":"Long term l-DOPA treatment causes production of 6-OHDA in the mouse striatum: involvement of hydroxyl radical","volume":"16","author":"Borah","year":"2009","journal-title":"Ann. Neurosci."},{"key":"10.1016\/j.brainres.2010.05.010_bib5","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1111\/j.1600-079X.2009.00713.x","article-title":"Melatonin inhibits 6-hydroxydopamine production in the brain to protect against experimental parkinsonism in rodents","volume":"47","author":"Borah","year":"2009","journal-title":"J. Pineal Res."},{"key":"10.1016\/j.brainres.2010.05.010_bib6","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/j.neuint.2009.11.008","article-title":"l-DOPA-induced 6-hydroxydopamine production in the striata of rodents is sensitive to the degree of denervation","volume":"56","author":"Borah","year":"2010","journal-title":"Neurochem. Int."},{"key":"10.1016\/j.brainres.2010.05.010_bib7","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/S1353-8020(02)00022-6","article-title":"Selective destruction of dopaminergic neurons by low concentrations of 6-OHDA and MPP+: protection by acetylsalicylic acid (aspirin)","volume":"8","author":"Carrasco","year":"2002","journal-title":"Parkinsonism Relat. Disord."},{"key":"10.1016\/j.brainres.2010.05.010_bib8","doi-asserted-by":"crossref","first-page":"S263","DOI":"10.1016\/S1353-8020(08)70014-2","article-title":"l-DOPA-induced dyskinesia: cellular mechanisms and approaches to treatment","volume":"13","author":"Cenci","year":"2007","journal-title":"Parkinsonism Relat. Disord."},{"key":"10.1016\/j.brainres.2010.05.010_bib9","doi-asserted-by":"crossref","first-page":"5322","DOI":"10.1523\/JNEUROSCI.18-14-05322.1998","article-title":"Hippocampal neurotoxicity of Delta9-tetrahydrocannabinol","volume":"18","author":"Chan","year":"1998","journal-title":"J. Neurosci."},{"key":"10.1016\/j.brainres.2010.05.010_bib10","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1523\/JNEUROSCI.3602-07.2008","article-title":"Unregulated cytosolic dopamine causes neurodegeneration associated with oxidative stress in mice","volume":"28","author":"Chen","year":"2008","journal-title":"J. Neurosci."},{"key":"10.1016\/j.brainres.2010.05.010_bib11","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1111\/j.1749-6632.1994.tb21786.x","article-title":"In vivo generation of hydroxyl radicals and MPTP-induced dopaminergic toxicity in the basal ganglia","volume":"738","author":"Chiueh","year":"1994","journal-title":"Ann. NY Acad. Sci."},{"key":"10.1016\/j.brainres.2010.05.010_bib12","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/S0021-9673(00)90882-3","article-title":"Mass fragmentography of dopamine and 6-hydroxydopamine. Application to the determination of dopamine in human brain biopsies from the caudate nucleus","volume":"99","author":"Curtius","year":"1974","journal-title":"J. Chromatogr."},{"key":"10.1016\/j.brainres.2010.05.010_bib13","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1096\/fj.00-0129com","article-title":"Melatonin protects against 6-OHDA-induced neurotoxicity in rats: a role for mitochondrial complex I activity","volume":"15","author":"Dabbeni-Sala","year":"2001","journal-title":"FASEB J."},{"key":"10.1016\/j.brainres.2010.05.010_bib14","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1016\/S0140-6736(87)91361-4","article-title":"Increased nigral iron content in postmortem parkinsonian brain","volume":"2","author":"Dexter","year":"1987","journal-title":"Lancet"},{"key":"10.1016\/j.brainres.2010.05.010_bib15","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/0014-2999(93)90780-L","article-title":"Catecholamine uptake inhibitors elevate 6-hydroxydopamine in brain after administration of 6-hydroxydopa","volume":"232","author":"Evans","year":"1993","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.brainres.2010.05.010_bib16","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1007\/s002109900079","article-title":"Salicylate protects against MPTP-induced impairments in dopaminergic neurotransmission at the striatal and nigral level in mice","volume":"360","author":"Ferger","year":"1999","journal-title":"Naunyn-Schmiedeberg's Arch. Pharmacol."},{"key":"10.1016\/j.brainres.2010.05.010_bib17","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1006\/exnr.1993.1008","article-title":"Pre- and postsynaptic neurotoxic effects of dopamine demonstrated by intrastriatal injection","volume":"119","author":"Filloux","year":"1993","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.brainres.2010.05.010_bib18","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/S0079-6123(08)00923-0","article-title":"Parkinson's disease\u2014opportunities for novel therapeutics to reduce the problems of levodopa therapy","volume":"172","author":"Fox","year":"2008","journal-title":"Prog. Brain Res."},{"key":"10.1016\/j.brainres.2010.05.010_bib19","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1016\/S0026-895X(25)13535-9","article-title":"Oxidative pathways for catecholamines in the genesis of neuromelanin and cytotoxic quinones","volume":"14","author":"Graham","year":"1978","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.brainres.2010.05.010_bib20","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1126\/science.274.5291.1383","article-title":"Neuroprotection by aspirin and sodium salicylate through blockade of NF-kappaB activation","volume":"274","author":"Grilli","year":"1996","journal-title":"Science"},{"key":"10.1016\/j.brainres.2010.05.010_bib21","doi-asserted-by":"crossref","first-page":"1956","DOI":"10.1073\/pnas.93.5.1956","article-title":"Role of oxidation in the neurotoxic effects of intrastriatal dopamine injections","volume":"93","author":"Hastings","year":"1996","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"10.1016\/j.brainres.2010.05.010_bib22","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.brainres.2005.06.020","article-title":"Reactive oxidative and nitrogen species in the nigrostriatal system following striatal 6-hydroxydopamine lesion in rats","volume":"1052","author":"Henze","year":"2005","journal-title":"Brain Res."},{"key":"10.1016\/j.brainres.2010.05.010_bib23","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/S0304-3940(00)01320-3","article-title":"Repeated administration of high dose levodopa enhances hydroxyl radical production in the rat striatum denervated with 6-hydroxydopamine","volume":"290","author":"Ishida","year":"2000","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.brainres.2010.05.010_bib24","doi-asserted-by":"crossref","first-page":"S39","DOI":"10.1212\/WNL.50.6_Suppl_6.S39","article-title":"Levodopa neurotoxicity: experimental studies versus clinical relevance","volume":"50","author":"Jenner","year":"1998","journal-title":"Neurology"},{"key":"10.1016\/j.brainres.2010.05.010_bib25","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1111\/j.1471-4159.1993.tb13630.x","article-title":"Absence of 6-hydroxydopamine in the rat brain after treatment with stimulants and other dopaminergic agents: a mass fragmentographic study","volume":"61","author":"Karoum","year":"1993","journal-title":"J. Neurochem."},{"key":"10.1016\/j.brainres.2010.05.010_bib26","doi-asserted-by":"crossref","first-page":"419","DOI":"10.3109\/10715769709065781","article-title":"Hydroxyl radical scavenging activity of nonsteroidal anti-inflammatory drugs","volume":"27","author":"Kataoka","year":"1997","journal-title":"Free Radic. Res."},{"key":"10.1016\/j.brainres.2010.05.010_bib27","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1254\/jjp.28.789","article-title":"Subcellular distribution of ascorbic acid in rat brain","volume":"28","author":"Kuo","year":"1978","journal-title":"Jpn J. Pharmacol."},{"key":"10.1016\/j.brainres.2010.05.010_bib28","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/S0300-483X(01)00541-8","article-title":"Deprenyl protects from MPTP-induced Parkinson-like syndrome and glutathione oxidation in rat striatum","volume":"170","author":"Leret","year":"2002","journal-title":"Toxicology"},{"key":"10.1016\/j.brainres.2010.05.010_bib29","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1007\/s00702-002-0829-x","article-title":"Striatal formation of 6-hydroxydopamine in mice treated with pargyline, pyrogallol and methamphetamine","volume":"110","author":"Liao","year":"2003","journal-title":"J. Neural Transm."},{"key":"10.1016\/j.brainres.2010.05.010_bib30","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/S0197-0186(03)00170-0","article-title":"Acetaminophen and aspirin inhibit superoxide anion generation and lipid peroxidation, and protect against 1-methyl-4-phenyl pyridinium-induced dopaminergic neurotoxicity in rats","volume":"44","author":"Maharaj","year":"2004","journal-title":"Neurochem. Int."},{"key":"10.1016\/j.brainres.2010.05.010_bib31","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.brainres.2005.09.041","article-title":"l-DOPA administration enhances 6-hydroxydopamine generation","volume":"1063","author":"Maharaj","year":"2005","journal-title":"Brain Res."},{"key":"10.1016\/j.brainres.2010.05.010_bib32","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/0006-8993(81)90056-1","article-title":"Regional distribution of ascorbate in human brain","volume":"212","author":"Mefford","year":"1981","journal-title":"Brain Res."},{"key":"10.1016\/j.brainres.2010.05.010_bib33","series-title":"Neurotoxic Factors in Parkinson's Disease and Related Disorders","first-page":"289","article-title":"Neurochemical mechanisms underlying neuroprotective actions of bromocriptine, salicylate, d- and l-deprenyl in neurodegeneration caused by MPTP","author":"Mohanakumar","year":"2000"},{"key":"10.1016\/j.brainres.2010.05.010_bib34","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1111\/j.1749-6632.1994.tb21828.x","article-title":"Ferrous-citrate complex and nigral degeneration: evidence for free radical formation and lipid peroxidation","volume":"738","author":"Mohanakumar","year":"1994","journal-title":"Ann. NY Acad. Sci."},{"key":"10.1016\/j.brainres.2010.05.010_bib35","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/S0006-8993(00)02189-2","article-title":"Neuroprotection by sodium salicylate against 1-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine-induced neurotoxicity","volume":"864","author":"Mohanakumar","year":"2000","journal-title":"Brain Res."},{"key":"10.1016\/j.brainres.2010.05.010_bib36","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1111\/j.1749-6632.2002.tb04083.x","article-title":"Nitric oxide: an antioxidant and neuroprotector","volume":"962","author":"Mohanakumar","year":"2002","journal-title":"Ann. NY Acad. Sci."},{"key":"10.1016\/j.brainres.2010.05.010_bib37","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/j.neuron.2009.01.033","article-title":"Interplay between cytosolic dopamine, calcium, and alpha-synuclein causes selective death of substantia nigra neurons","volume":"62","author":"Mosharov","year":"2009","journal-title":"Neuron"},{"key":"10.1016\/j.brainres.2010.05.010_bib38","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/j.neuint.2009.04.013","article-title":"Striatal dopamine level contributes to hydroxyl radical generation and subsequent neurodegeneration in the striatum in 3-nitropropionic acid-induced Huntington's disease in rats","volume":"55","author":"Pandey","year":"2009","journal-title":"Neurochem. Int."},{"key":"10.1016\/j.brainres.2010.05.010_bib39","series-title":"The Rat Brain in Stereotaxic Coordinates","author":"Paxinos","year":"1998"},{"key":"10.1016\/j.brainres.2010.05.010_bib40","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/0014-2999(86)90011-7","article-title":"Failure to detect 6-hydroxydopamine in rat striatum after the dopamine releasing drugs dexamphetamine, methylamphetamine and MPTP","volume":"132","author":"Rollema","year":"1986","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.brainres.2010.05.010_bib41","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/S0006-8993(02)04174-4","article-title":"Non-steroidal anti-inflammatory drug sodium salicylate, but not diclofenac or celecoxib, protects against 1-methyl-4-phenyl pyridinium-induced dopaminergic neurotoxicity in rats","volume":"966","author":"Sairam","year":"2003","journal-title":"Brain Res."},{"key":"10.1016\/j.brainres.2010.05.010_bib42","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.neuint.2005.12.016","article-title":"l-Deprenyl protects against rotenone-induced, oxidative stress mediated dopaminergic neurodegeneration in rats","volume":"49","author":"Saravanan","year":"2006","journal-title":"Neurochem. Int."},{"key":"10.1016\/j.brainres.2010.05.010_bib43","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1111\/j.1468-1331.2009.02697.x","article-title":"Levodopa in the treatment of Parkinson's disease","volume":"16","author":"Schapira","year":"2009","journal-title":"Eur. J. Neurol."},{"key":"10.1016\/j.brainres.2010.05.010_bib44","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/0091-3057(84)90125-4","article-title":"Formation of 6-hydroxydopamine in caudate nucleus of the rat brain after a single large dose of methyl amphetamine","volume":"21","author":"Seiden","year":"1984","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.brainres.2010.05.010_bib45","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.bbr.2007.06.025","article-title":"Unilateral implantation of dopamine-loaded biodegradable hydrogel in the striatum attenuates motor abnormalities in the 6-hydroxydopamine model of hemi-parkinsonism","volume":"184","author":"Senthilkumar","year":"2007","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.brainres.2010.05.010_bib46","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/j.brainres.2005.10.084","article-title":"Physiological neuroprotection by melatonin in a 6-hydroxydopamine model of Parkinson's disease","volume":"1068","author":"Sharma","year":"2006","journal-title":"Brain Res."},{"key":"10.1016\/j.brainres.2010.05.010_bib47","doi-asserted-by":"crossref","first-page":"15466","DOI":"10.1016\/S0021-9258(17)36277-4","article-title":"Hydroxyl radical attack on dopamine","volume":"260","author":"Slivka","year":"1985","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.brainres.2010.05.010_bib48","doi-asserted-by":"crossref","first-page":"1526","DOI":"10.1016\/j.bcp.2007.12.010","article-title":"Inhibition of 6-hydroxydopamine-induced oxidative damage by 4,5-dihydro-3H-2-benzazepine N-oxides","volume":"75","author":"Soto-Otero","year":"2008","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.brainres.2010.05.010_bib49","doi-asserted-by":"crossref","first-page":"95","DOI":"10.3109\/10715769609088005","article-title":"Evaluation of the pro-oxidant and antioxidant actions of l-DOPA and dopamine in vitro: implications for Parkinson's disease","volume":"24","author":"Spencer","year":"1996","journal-title":"Free Radic. Res."},{"key":"10.1016\/j.brainres.2010.05.010_bib50","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1002\/1098-2396(200102)39:2<167::AID-SYN8>3.0.CO;2-U","article-title":"Inhibition of the cyclooxygenase isoenzymes COX-1 and COX-2 provide neuroprotection in the MPTP-mouse model of Parkinson's disease","volume":"39","author":"Teismann","year":"2001","journal-title":"Synapse"},{"key":"10.1016\/j.brainres.2010.05.010_bib51","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/S0006-8993(99)02202-7","article-title":"In vivo hydroxyl radical generation in the striatum following systemic administration of 1-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine in mice","volume":"852","author":"Thomas","year":"2000","journal-title":"Brain Res."},{"key":"10.1016\/j.brainres.2010.05.010_bib52","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1021\/jm00223a008","article-title":"Potential oxidative pathways of brain catecholamines","volume":"19","author":"Tse","year":"1976","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.brainres.2010.05.010_bib53","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/0006-8993(70)90187-3","article-title":"Quantitative recording of rotational behaviour in rats after 6-hydroxydopamine lesions of the nigrostriatal dopamine system","volume":"24","author":"Ungerstedt","year":"1970","journal-title":"Brain Res."},{"key":"10.1016\/j.brainres.2010.05.010_bib54","doi-asserted-by":"crossref","first-page":"S78","DOI":"10.1007\/s000110050284","article-title":"Anti-inflammatory drugs and their mechanism of action","volume":"47","author":"Vane","year":"1998","journal-title":"Inflamm. Res."},{"key":"10.1016\/j.brainres.2010.05.010_bib55","doi-asserted-by":"crossref","first-page":"5292","DOI":"10.1073\/pnas.96.9.5292","article-title":"Suppression of inducible cyclooxygenase 2 gene transcription by aspirin and sodium salicylate","volume":"96","author":"Xu","year":"1999","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"10.1016\/j.brainres.2010.05.010_bib56","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/0891-5849(95)00042-V","article-title":"Elevated extracellular glutamate levels increased the formation of hydroxyl radical in the striatum of anesthetized rat","volume":"19","author":"Yang","year":"1995","journal-title":"Free Radic. Biol. Med."}],"container-title":["Brain Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006899310010899?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006899310010899?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,13]],"date-time":"2025-09-13T17:42:33Z","timestamp":1757785353000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006899310010899"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,7]]},"references-count":56,"alternative-id":["S0006899310010899"],"URL":"https:\/\/doi.org\/10.1016\/j.brainres.2010.05.010","relation":{},"ISSN":["0006-8993"],"issn-type":[{"value":"0006-8993","type":"print"}],"subject":[],"published":{"date-parts":[[2010,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Salicylic acid protects against chronic l-DOPA-induced 6-OHDA generation in experimental model of parkinsonism","name":"articletitle","label":"Article Title"},{"value":"Brain Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.brainres.2010.05.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2010 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}